Skip to main content

Year: 2024

CORRECTION – Bogota Financial Corp. Reports Results for the Three and Nine Months Ended September 30, 2024 Corrected

TEANECK, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) — Bogota Financial Corp. (NASDAQ: BSBK) (the “Company”), the holding company of Bogota Savings Bank (the “Bank”), after market close today issued a correction to its financial results for the three and nine months ended September 30, 2024 (the “Revised Earnings Release”), which was issued prior to market open on November 1, 2024 (the “Original Earnings Release”). Interest expense on deposits (and similarly total interest expense) for the three and nine months ended September 30, 2024 reported in the Original Earnings Release was understated by $300,000 due to a misstatement of the rates paid on certain certificates of deposit during the three months ended September 30, 2024. As a result, the Revised Earnings Release reflects the following changes: At September 30, 2024    Average...

Continue reading

Euro Sun Announces $2.15 Million Private Placement

NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it intends to complete a non-brokered private placement financing of up to 43,000,000 units of the Company (the “Units”) at a price of C$0.05 per Unit for gross proceeds to the Company of up to approximately C$2.15 million (the “Offering”). Each Unit will consist of one common share of Euro Sun and one share purchase warrant of Euro Sun (“Warrant”). Each Warrant will be exercisable to acquire one common share of Euro Sun at a price of C$0.05 per share for 24 months from the closing of the Offering. Closing of the Offering is expected to occur on or about December 13, 2024 and may close in one or more tranches. All securities issued...

Continue reading

Madison Pacific Properties Inc. announces the results for the year ended August 31, 2024

VANCOUVER, British Columbia, Nov. 01, 2024 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces the results of operations for the year ended August 31, 2024. The results reported are pursuant to International Financial Reporting Standards (IFRS) for public companies. For the year ended August 31, 2024, the Company is reporting a net loss of $44.2 million (2023: net income of $19.0 million); cash flows generated from operating activities before changes in non-cash operating balances of $11.4 million (2023: $9.5 million); and loss per share of $0.74 (2023: income per share of $0.31). Included in net loss is a provision of $51.5 million (2023: $nil) for uncertain tax positions recognizing a tax liability for unpaid taxes, estimated interest expense and...

Continue reading

Fobi AI Responds To CTO (Cease Trade Order) Commitment To Financial Transparency and Audit Completion

VANCOUVER, BC, Nov. 01, 2024 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI:TSXV)(FOBIF: OTCQB) (the “Company” or “Fobi”), an industry leader in harnessing AI and data intelligence to enable digital transformation, acknowledges the recent issuance of a Cease Trade Order by regulatory authorities due to the non-filing of the annual 2024 financial documents. “We want to assure our shareholders, stakeholders, and the public that the Company is fully committed to resolving this situation and completing the financial audit as quickly as possible. Rob Anson, CEO of Fobi AI, states: “The delay in completing our 2024 annual filing is certainly disappointing. Unlike last year, we chose not to proactively file for an MCTO because we were confident in meeting our filing deadline. I want to assure you that our team and auditors are fully committed...

Continue reading

First National Bank Alaska declares regular and special dividends for fourth quarter, both payable in December

ANCHORAGE, Alaska, Nov. 01, 2024 (GLOBE NEWSWIRE) — At the Board of Directors meeting held Oct. 31, 2024, First National Bank Alaska (OTCQX:FBAK) declared a cash dividend of $3.20 per share for shareholders of record as of Dec. 1, 2024, payable on Dec. 15, 2024 with distribution on Dec. 16. At the same meeting, the Board declared a special cash dividend of $3.20 per share for shareholders of record as of Dec. 1, 2024, payable and for distribution on Dec. 19, 2024. CONTACT: Cheri GillianSecretary to the Board of Directors907-777-3409

Continue reading

Prime Drink Group Announces Closing of Triani Canada Acquisition

MONTREAL, Nov. 01, 2024 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces it has closed its acquisition of all the issued and outstanding shares (“Triani Shares”) of Triani Canada Inc. (the “Transaction”) from 9296-0186 Québec Inc. (“9296”) and Angelpart Ventures Inc. (collectively, the “Vendors”), pursuant to the amended and restated share purchase agreement dated August 7, 2024 (the “Amended and Restated SPA”) entered into between the Vendors, the shareholders of 9296, and Prime. All dollar figures provided herein are in Canadian dollars unless otherwise stated. Acquisition of Triani Pursuant to the Amended and Restate SPA, Prime acquired the Triani Shares from the Vendors in consideration for:(i) CAD$11,400,000 payable through the issuance of an aggregate of 91,200,000 common shares...

Continue reading

ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024

Poster presentation will highlight new data from clinical trial evaluating evorpacept, a highly differentiated investigational CD47 blocker, in combination with zanidatamab, an investigational dual HER2-targeted bispecific antibody, in patients with advanced breast cancers SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients’ lives, today announced that results from a Phase 1b/2 combination trial evaluating ALX Oncology’s evorpacept in combination with Jazz Pharmaceuticals’ zanidatamab in HER2-positive and HER2-low metastatic breast cancer have been accepted for a poster spotlight presentation at the San Antonio...

Continue reading

OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium

OnKure to host a conference call to review key data presented at SABCS and provide a general corporate update on Friday, December 13, 2024 at 8:00 a.m. ET BOULDER, Colo., Nov. 01, 2024 (GLOBE NEWSWIRE) — OnKure Therapeutics, Inc. (NASDAQ: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines in oncology, today announced that two abstracts discussing preliminary clinical data and preclinical data for OKI-219, a potential best-in-class, mutant-selective PI3KαH1047R inhibitor, have been selected for presentation during poster sessions at the 2024 San Antonio Breast Cancer Symposium (SABCS), which is being held virtually and in person from December 10–13, 2024. Poster presentation details:Poster Title: Preliminary results from PIKture-01, a First-in-Human Study of OKI-219, a mutant...

Continue reading

Beasley Broadcast Group to Report 2024 Third Quarter Financial Results, Host Conference Call and Webcast on November 5

NAPLES, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) — Beasley Broadcast Group, Inc. (Nasdaq: BBGI) (“Beasley” or the “Company”), a multi-platform media company, announced today that it will report its 2024 third quarter financial results before the market opens on Tuesday, November 5, 2024. The Company will host a conference call and webcast at 11:30 a.m. ET that morning to review the results. To access the conference call, interested parties may dial 877-407-4018 or 201-689-8471, conference ID  13749767 (domestic and international callers). Participants can also listen to a live webcast of the call at the Company’s website at www.bbgi.com. Please allow 15 minutes to register and download and install any necessary software. Following its completion, a replay of the webcast can be accessed for five days on the Company’s website, www.bbgi.com. Questions...

Continue reading

South Bow Recommends Shareholders Reject TRC Capital’s Below-market “Mini-tender” Offer

CALGARY, Alberta, Nov. 01, 2024 (GLOBE NEWSWIRE) — South Bow Corp. (TSX & NYSE: SOBO) has received an unsolicited “mini-tender” offer from TRC Capital Investment Corp. (TRC Capital) to purchase up to 3 million South Bow common shares, or approximately 1.4% of South Bow’s outstanding common shares, at a below-market price of C$31.95. South Bow does not endorse TRC Capital’s unsolicited offer, has no affiliation with TRC Capital or its offer, and does not recommend or endorse this unsolicited mini-tender offer. South Bow cautions shareholders that the mini-tender offer has been made at a below-market price for the South Bow common shares. TRC Capital’s unsolicited offer price of C$31.95 per share represents a discount of 4.6% to the closing price of the South Bow common shares on the Toronto Stock Exchange...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.